Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Occidental Petroleum Corporation. A complete text table follows the diagram.
Upstream remains the continuing profit engine, midstream loses money, and the OxyChem sale creates a one-time windfall used alongside a major debt paydown
Swipe to explore
The diagram deliberately separates recurring continuing operations from the OxyChem discontinued-operation gain. It does not imply that all $9,502M of sale cash maps directly to the quarter's $6,903M debt repayment, although the filing shows both as central cash-flow events.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Oil & gas core | 1 | $1.0B | Continuing segment income before tax |
| Continuing pretax income | 2 | $390M | Core result after portfolio and financing costs |
| Midstream & marketing loss | 2 | $87M | Derivatives, impairments and asset-sale losses |
| Corporate & eliminations | 2 | $108M | Unallocated continuing costs |
| Interest & debt expense | 2 | $432M | Includes early debt-extinguishment cost |
| Continuing income | 3 | $236M | Recurring-company result after tax |
| Continuing income tax | 3 | $154M | Reported tax expense |
| OxyChem discontinued operations | 3 | $3.1B | After-tax sale gain and discontinued result |
| Total net income | 4 | $3.4B | 93% came from discontinued operations |
| Common stockholders | 5 | $3.2B | $3.13 diluted EPS |
| Preferred dividends | 5 | $170M | Berkshire-era preferred capital |
| Noncontrolling interests | 5 | $14M | Partner-owned earnings |
| From | To | Value |
|---|---|---|
| Oil & gas core | Continuing pretax income | $390M |
| Oil & gas core | Midstream & marketing loss | $87M |
| Oil & gas core | Corporate & eliminations | $108M |
| Oil & gas core | Interest & debt expense | $432M |
| Continuing pretax income | Continuing income | $236M |
| Continuing pretax income | Continuing income tax | $154M |
| Continuing income | Total net income | $236M |
| OxyChem discontinued operations | Total net income | $3.1B |
| Total net income | Common stockholders | $3.2B |
| Total net income | Preferred dividends | $170M |
| Total net income | Noncontrolling interests | $14M |